Helping the Community and the World One Patient at a Time
Current Enrolling Clinical Trials
VERISMO
BA39731 Phase 4 An Observational Study Of Ocrelizumab Patients With Multiple Sclerosis To Determine the Incidence And Mortality Rates Of Breast Cancer and All Malignancies (VERISMO STUDY)
Celgene /Bristol Myers Squibb ENLIGHTEN
A Multicenter, Longitudinal, Open-Label, Single -Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)
Lundbeck NA, Ltd.
A Clinical study of Patients with Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy.
Novartis - Exchange
Exploring the safety and tolerability of conversion from oral or injectable disease modifying therapies to dose titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis
EMD - Serono
The study will evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Interferon-beta-1a (Avonex®), once a week intramuscularly in participants with Relapsing Multiple Sclerosis (RMS).
Display their FAQs
Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.
Current enrolling clinical trials
ADDEX ADX48621
ADX48621-301A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
Genentech Inc.
Genentech WA40404
A phase IIIb multi-center, randomized double-blind, placebo controlled study to evaluate the efficacy and safety of Ocrelizumab in adults with primary progressive multiple sclerosis.
ROCHE - FENtrepid
GN41791 A phase lll Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy and Safety of Fenebrutinib Compared With Primary Progressive Multiple Sclerosis